Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 146

    1.

    Amylin agonists: a novel approach in the treatment of diabetes.

    Schmitz O, Brock B, Rungby J.

    Diabetes. 2004 Dec;53 Suppl 3:S233-8. Review.PMID: 15561917 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Amylin receptor agonists: a novel pharmacological approach in the management of insulin-treated diabetes mellitus.

    Nyholm B, Brock B, Ørskov L, Schmitz O.

    Expert Opin Investig Drugs. 2001 Sep;10(9):1641-52. Review.PMID: 11772274 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pramlintide in the treatment of diabetes mellitus.

    Edelman S, Maier H, Wilhelm K.

    BioDrugs. 2008;22(6):375-86. doi: 10.2165/0063030-200822060-00004. Review.PMID: 18998755 [PubMed - indexed for MEDLINE]Related articles

    4.

    Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control.

    Weyer C, Maggs DG, Young AA, Kolterman OG.

    Curr Pharm Des. 2001 Sep;7(14):1353-73. Review. Erratum in: Curr Pharm Des 2001 Dec;7(18):1967. PMID: 11472273 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical implications of amylin and amylin deficiency.

    Kruger DF, Gatcomb PM, Owen SK.

    Diabetes Educ. 1999 May-Jun;25(3):389-97; quiz 398. Review.PMID: 10531859 [PubMed - indexed for MEDLINE]Related articles

    6.

    Inhibition of glucagon secretion.

    Young A.

    Adv Pharmacol. 2005;52:151-71. Review.PMID: 16492545 [PubMed - indexed for MEDLINE]Related articles

    7.

    Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone.

    Edelman SV, Weyer C.

    Diabetes Technol Ther. 2002;4(2):175-89. Review.PMID: 12079621 [PubMed - indexed for MEDLINE]Related articles

    8.

    Optimizing diabetes treatment using an amylin analogue.

    Edelman SV.

    Diabetes Educ. 2008 Jan-Feb;34 Suppl 1:4S-10S.PMID: 18268000 [PubMed - indexed for MEDLINE]Related articles

    9.

    Amylin replacement therapy in patients with insulin-requiring type 2 diabetes.

    Owen SK.

    Diabetes Educ. 2006 May-Jun;32 Suppl 3:105S-110S.PMID: 16751351 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pramlintide in the treatment of type 1 and type 2 diabetes mellitus.

    Ryan GJ, Jobe LJ, Martin R.

    Clin Ther. 2005 Oct;27(10):1500-12. Review.PMID: 16330288 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pramlintide for the treatment of diabetes mellitus.

    Kleppinger EL, Vivian EM.

    Ann Pharmacother. 2003 Jul-Aug;37(7-8):1082-9. Review.PMID: 12841822 [PubMed - indexed for MEDLINE]Related articles

    12.

    Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes.

    Pullman J, Darsow T, Frias JP.

    Vasc Health Risk Manag. 2006;2(3):203-12. Review.PMID: 17326327 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Pramlintide: (AC 137, AC 0137, Symlin, Tripro-Amylin).

    [No authors listed]

    BioDrugs. 2003;17(1):73-9. Review.PMID: 12534323 [PubMed - indexed for MEDLINE]Related articles

    14.

    [Role of amylin in glucose homeostasis and its perspective use in diabetes management]

    Otto-Buczkowska E, Mazur-Dworzecka U, Dworzecki T.

    Przegl Lek. 2008;65(3):135-9. Review. Polish. PMID: 18624122 [PubMed - indexed for MEDLINE]Related articles

    15.

    Amylin replacement therapy in patients with type 1 diabetes.

    Edelman SV, Caballero L.

    Diabetes Educ. 2006 May-Jun;32 Suppl 3:119S-127S.PMID: 16751353 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus.

    Singh-Franco D, Robles G, Gazze D.

    Clin Ther. 2007 Apr;29(4):535-62. Review.PMID: 17617279 [PubMed - indexed for MEDLINE]Related articles

    17.

    The role of amylin in the physiology of glycemic control.

    Scherbaum WA.

    Exp Clin Endocrinol Diabetes. 1998;106(2):97-102. Review.PMID: 9628238 [PubMed - indexed for MEDLINE]Related articles

    18.

    The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes.

    Fineman MS, Koda JE, Shen LZ, Strobel SA, Maggs DG, Weyer C, Kolterman OG.

    Metabolism. 2002 May;51(5):636-41.PMID: 11979398 [PubMed - indexed for MEDLINE]Related articles

    19.

    Therapies for diabetes: pramlintide and exenatide.

    Jones MC.

    Am Fam Physician. 2007 Jun 15;75(12):1831-5.PMID: 17619527 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of amylin and the amylin agonist pramlintide on glucose metabolism.

    Schmitz O, Nyholm B, Orskov L, Gravholt C, Møller N.

    Diabet Med. 1997 Jun;14 Suppl 2:S19-23. Review.PMID: 9212325 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Recent activity

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...